JSP Pharmaceutical Manufacturing (Thailand) Public Company Limited(TH:JSP)
฿1.670.00 (0.00%)
TH:JSP
JSP Pharmaceutical Manufacturing (Thailand) Public Company Limited financials statements
฿1.67
At close:0.00 (0.00%)
JSP Pharmaceutical Manufacturing (Thailand) Public Company Limited (JSP) Ratios
JSP Pharmaceutical Manufacturing (Thailand) Public Company Limited Ratios
TH:JSP's free cash flow for Q2 2026 was ฿36.86M. For the 2026 fiscal year, TH:JSP's free cash flow was decreased by ฿-5.68M and operating cash flow was ฿42.54M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.39 | 1.37 | 1.26 | 4.49 | 7.19 |
| Quick Ratio | 0.96 | 0.84 | 0.74 | 3.61 | 6.24 |
| Cash Ratio | 0.20 | 0.13 | 0.11 | 0.86 | 5.44 |
| Solvency Ratio | 0.26 | 0.15 | 0.11 | 0.03 | 0.18 |
| Operating Cash Flow Ratio | 0.50 | 0.58 | 0.21 | -0.05 | 0.45 |
| Short-Term Operating Cash Flow Coverage | 1.22 | 1.56 | 0.41 | -0.18 | 4.02 |
| Net Current Asset Value | ฿ -208.90M | ฿ -130.47M | ฿ -159.56M | ฿ 222.92M | ฿ 529.93M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.26 | 0.22 | 0.22 | 0.13 | 0.15 |
| Debt-to-Equity Ratio | 0.42 | 0.34 | 0.33 | 0.17 | 0.19 |
| Debt-to-Capital Ratio | 0.30 | 0.25 | 0.25 | 0.15 | 0.16 |
| Long-Term Debt-to-Capital Ratio | 0.20 | 0.06 | 0.06 | 0.04 | 0.07 |
| Financial Leverage Ratio | 1.61 | 1.55 | 1.54 | 1.30 | 1.30 |
| Debt Service Coverage Ratio | 0.74 | 0.45 | 0.79 | 1.00 | 2.70 |
| Interest Coverage Ratio | 4.67 | 6.34 | -0.08 | -1.64 | 4.64 |
| Debt to Market Cap | 0.37 | 0.14 | 0.14 | 0.04 | 0.03 |
| Interest Debt Per Share | 0.83 | 0.64 | 0.65 | 0.37 | 0.54 |
| Net Debt to EBITDA | 2.42 | 5.71 | 2.77 | 1.85 | -6.25 |
| Profitability Margins | |||||
| Gross Profit Margin | 40.14% | 36.99% | 24.94% | 28.62% | 34.18% |
| EBIT Margin | 6.73% | -2.03% | 8.60% | 1.82% | 11.44% |
| EBITDA Margin | 13.61% | 5.50% | 16.90% | 8.10% | 16.70% |
| Operating Profit Margin | 6.73% | 12.74% | -0.19% | -3.51% | 11.44% |
| Pretax Profit Margin | 9.90% | -4.04% | 6.42% | -5.00% | 8.86% |
| Net Profit Margin | 6.72% | 0.55% | -0.22% | -4.08% | 7.03% |
| Continuous Operations Profit Margin | 4.47% | -4.02% | 4.76% | -0.72% | 7.03% |
| Net Income Per EBT | 67.87% | -13.59% | -3.43% | 81.55% | 79.32% |
| EBT Per EBIT | 147.04% | -31.71% | -3471.54% | 142.39% | 77.50% |
| Return on Assets (ROA) | 4.64% | 0.34% | -0.09% | -1.43% | 2.36% |
| Return on Equity (ROE) | 7.47% | 0.53% | -0.15% | -1.86% | 3.07% |
| Return on Capital Employed (ROCE) | 5.54% | 9.56% | -0.09% | -1.36% | 4.21% |
| Return on Invested Capital (ROIC) | 2.30% | 8.71% | -0.06% | -1.07% | 3.30% |
| Return on Tangible Assets | 4.76% | 0.35% | -0.10% | -1.44% | 2.36% |
| Earnings Yield | 7.53% | 0.47% | -0.11% | -1.06% | 1.11% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.67 | 5.10 | 4.69 | 3.99 | 6.70 |
| Payables Turnover | 13.19 | 9.72 | 9.90 | 6.62 | 6.90 |
| Inventory Turnover | 5.96 | 4.24 | 4.23 | 3.09 | 2.54 |
| Fixed Asset Turnover | 0.94 | 0.91 | 0.67 | 0.64 | 1.07 |
| Asset Turnover | 0.69 | 0.62 | 0.43 | 0.35 | 0.34 |
| Working Capital Turnover Ratio | 11.46 | 12.12 | 2.60 | 0.78 | 1.28 |
| Cash Conversion Cycle | 97.94 | 119.98 | 127.18 | 154.64 | 145.36 |
| Days of Sales Outstanding | 64.38 | 71.52 | 77.77 | 91.49 | 54.49 |
| Days of Inventory Outstanding | 61.23 | 86.01 | 86.30 | 118.29 | 143.75 |
| Days of Payables Outstanding | 27.67 | 37.56 | 36.88 | 55.14 | 52.88 |
| Operating Cycle | 125.61 | 157.54 | 164.06 | 209.79 | 198.24 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.25 | 0.28 | 0.09 | -0.01 | 0.14 |
| Free Cash Flow Per Share | -0.34 | 0.16 | -0.28 | -0.65 | 0.04 |
| Dividend Paid and CapEx Coverage Ratio | 0.39 | 1.85 | 0.22 | -0.02 | 0.79 |
| Capital Expenditure Coverage Ratio | 0.42 | 2.34 | 0.23 | -0.02 | 1.39 |
| Operating Cash Flow Coverage Ratio | 0.31 | 0.46 | 0.14 | -0.03 | 0.28 |
| Operating Cash Flow to Sales Ratio | 0.12 | 0.16 | 0.07 | -0.01 | 0.12 |
| Free Cash Flow Yield | -17.87% | 7.90% | -12.03% | -17.94% | 0.55% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 13.57 | 212.63 | -874.07 | -94.27 | 89.81 |
| Price-to-Sales (P/S) Ratio | 0.89 | 1.16 | 1.92 | 3.84 | 6.32 |
| Price-to-Book (P/B) Ratio | 0.99 | 1.12 | 1.27 | 1.75 | 2.76 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -5.60 | 12.66 | -8.31 | -5.57 | 182.21 |
| Price-to-Operating Cash Flow Ratio | 7.63 | 7.26 | 27.44 | -319.60 | 51.58 |
| Price-to-Earnings Growth (PEG) Ratio | 0.01 | -0.47 | 9.40 | 0.64 | 6.97 |
| Enterprise Value Multiple | 8.98 | 26.84 | 14.16 | 49.30 | 31.58 |
| Enterprise Value | 1.23B | 1.22B | 1.38B | 1.71B | 2.23B |
| EV to EBITDA | 8.98 | 26.84 | 14.16 | 49.30 | 31.58 |
| EV to Sales | 1.22 | 1.48 | 2.39 | 3.99 | 5.27 |
| EV to Free Cash Flow | -7.66 | 16.09 | -10.34 | -5.79 | 152.13 |
| EV to Operating Cash Flow | 10.45 | 9.22 | 34.13 | -332.07 | 43.06 |
| Tangible Book Value Per Share | 1.88 | 1.78 | 1.90 | 2.06 | 2.67 |
| Shareholders’ Equity Per Share | 1.91 | 1.81 | 1.85 | 2.07 | 2.68 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.55 | 0.00 | 0.25 | 0.18 | 0.21 |
| Revenue Per Share | 2.13 | 1.74 | 1.23 | 0.94 | 1.17 |
| Net Income Per Share | 0.14 | 0.01 | -0.00 | -0.04 | 0.08 |
| Tax Burden | 0.68 | -0.14 | -0.03 | 0.82 | 0.79 |
| Interest Burden | 1.47 | 1.99 | 0.75 | -2.74 | 0.77 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.30 | 0.25 | 0.27 | 0.33 | 0.24 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 2.62 | -3.98 | -31.80 | 0.29 | 1.74 |
Currency in THB
